Skip to main content

Advertisement

SpringerLink
Log in

Spektrum, Management und Vermeidung

Nebenwirkungen in der ästhetischen Medizin

  • gastbeitrag
  • Published:
ästhetische dermatologie & kosmetologie Aims and scope

Die ästhetische Medizin ist Bestandteil der Dermatologie, wie wir sie heute verstehen. Die ästhetische Dermatologie ist dort am wirkungsvollsten, sicher und kalkulierbar, wo sie sich wissenschaftliche Prinzipien zu eigen macht. In den letzten zwei Jahrzehnten haben deshalb auch zunehmend Methoden der evidenzbasierten Medizin wie randomisierte, kontrollierte Studien, systematische Reviews und Metaanalysen Eingang gefunden. Dennoch spielt noch immer die Erfahrungsmedizin eine größere Rolle [1].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Wollina U, Goldman A, Berger U, Abdel-Naser MB (2008) Esthetic and cosmetic dermatology. Dermatol Ther 21:118–130

    Article  PubMed  Google Scholar 

  2. Landau M (2008) Chemical peels. Clin Dermatol 26:200–208

    Article  PubMed  Google Scholar 

  3. Fischer TC, Perosino E, Poli F et al (2010) Chemical peels in aesthetic dermatology: an update 2009. J Eur Acad Dermatol Venereol 24:281–292

    Article  CAS  PubMed  Google Scholar 

  4. Wollina U (2011) Rejuvenation of the hand using caproyloyl acid peels. PRIME 4:16–17

    Article  Google Scholar 

  5. Rendon MI, Berson DS, Cohen JL et al (2010) Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthet Dermatol 3:32–43

    PubMed Central  PubMed  Google Scholar 

  6. Landau M (2007) Cardiac complications in deep chemical peels. Dermatol Surg 33:190–193

    Article  CAS  PubMed  Google Scholar 

  7. Sarkar R, Garg VK, Mysore V (2011) Position paper on mesotherapy. Indian J Dermatol Venereol Leprol 77:232–237

    Article  PubMed  Google Scholar 

  8. El-Domyati M, El-Ammawi TS, Moawad O et al (2012) Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. Int J Dermatol 51:913–919

    Article  PubMed Central  PubMed  Google Scholar 

  9. Jäger C, Brenner C, Habicht J, Wallich R (2012) Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro — a pilot study. Exp Dermatol 21:72–75

    Article  PubMed  Google Scholar 

  10. Sivagnanam G (2010) Mesotherapy — the french connection. J Pharmacol Pharmacother 1:4–8

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Ramos-e-Silva M, Pereira AL, Ramos-e-Silva S, Piñeiro-Maceira J (2012) Oleoma: rare complication of mesotherapy for cellulite. Int J Dermatol 51:162–167

    Article  CAS  PubMed  Google Scholar 

  12. Duque-Estrada B, Vincenzi C, Misciali C, Tosti A (2009) Alopecia secondary to mesotherapy. J Am Acad Dermatol 61:707–709

    Article  PubMed  Google Scholar 

  13. Kadry R, Hamadah I, Al-Issa A et al (2008) Multifocal scalp abscess with subcutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. J Drugs Dermatol 7:72–73

    PubMed  Google Scholar 

  14. Galmés-Truyols A, Giménez-Duran J, Bosch-Isabel C et al (2011) An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy. Enferm Infecc Microbiol Clin 29:510–514

    Article  PubMed  Google Scholar 

  15. Couderc C, Carbonne A, Thiolet JM et al (2011) Non-tuberculous mycobacterial infections related to esthetic care in France, 2001–2010. Med Mal Infect 41:379–383

    Article  CAS  PubMed  Google Scholar 

  16. Quiñones C, Ramalle-Gómara E, Perucha M et al (2010) An outbreak of Mycobacterium fortuitum cutaneous infection associated with mesotherapy. J Eur Acad Dermatol Venereol 24:604–606

    Article  PubMed  Google Scholar 

  17. Orjuela D, Puerto G, Mejía G et al (2010) Cutaneous tuberculosis after mesotherapy: report of six cases. Biomedica 30:321–326

    PubMed  Google Scholar 

  18. Centers for Disease Control and Prevention (CDC) (2005) Outbreak of mesotherapy-associated skin reactions — District of Columbia area, January–February 2005. MMWR Morb Mortal Wkly Rep 54:1127–1130

    Google Scholar 

  19. Correa NE, Cataño JC, Mejía GI et al (2010) Outbreak of mesotherapy-associated cutaneous infections caused by Mycobacterium chelonae in Colombia. Jpn J Infect Dis 63:143–145

    PubMed  Google Scholar 

  20. Palomar FJ, Mir P (2012) Neurophysiological changes after intramuscular injection of botulinum toxin. Clin Neurophysiol 123:54–60

    Article  CAS  PubMed  Google Scholar 

  21. Carruthers JA, Lowe NJ, Menter MA et al (2002) A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 46:840–849

    Article  PubMed  Google Scholar 

  22. Lowe NJ, Ascher B, Heckmann M et al (2005) Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow’s feet.Dermatol Surg 31:257–262

    Article  CAS  PubMed  Google Scholar 

  23. Rzany B, Ascher B, Fratila A et al (2006) Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 142:320–326

    Article  CAS  PubMed  Google Scholar 

  24. Brin MF, Boodhoo TI, Pogoda JM et al (2009) Safety and tolerability of onabotulinumtoxin A in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants. J Am Acad Dermatol 61:961–970

    Article  CAS  PubMed  Google Scholar 

  25. Imhof M, Kühne U (2011) A phase III study of incobotulinumtoxin A in the treatment of glabellar frown lines. J Clin Aesthet Dermatol 4:28–34

    PubMed Central  PubMed  Google Scholar 

  26. Michaels BM, Csank GA, Ryb GE et al (2012) Prospective randomized comparison of onabotulinumtoxin A (Botox) and abobotulinumtoxin A (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles. Aesthet Surg J 32:96–102

    Article  PubMed  Google Scholar 

  27. Sattler G, Callander MJ, Grablowitz D et al (2010) Noninferiority of incobotulinumtoxin A, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines. Dermatol Surg 36(Suppl 4):2146–2154

    Article  CAS  PubMed  Google Scholar 

  28. Cohen JL, Dayan SH, Cox SE et al (2012) Onabotulinumtoxin A dose-ranging study for hyperdynamic perioral lines. Dermatol Surg 38:1497–1505

    Article  CAS  PubMed  Google Scholar 

  29. Goldman A, Wollina U (2010) Elevation of the corner of the mouth using botulinum toxin type a. J Cutan Aesthet Surg 3:145–150

    Article  PubMed Central  PubMed  Google Scholar 

  30. Goldman A, Wollina U (2010) Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures. Clin Interv Aging 5:293–299

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Linder JS, Edmonson BC, Laquis SJ et al (2002) Skin cooling before periocular botulinum toxin A injection. Ophthal Plast Reconstr Surg 18:441–442

    Article  PubMed  Google Scholar 

  32. Wollina U, Konrad H (2005) Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol 6:141–150

    Article  PubMed  Google Scholar 

  33. Broughton G 2nd, Crosby MA, Coleman J, Rohrich RJ (2007) Use of herbal supplements and vitamins in plastic surgery: a practical review. Plast Reconstr Surg 119:48e–66e

    Article  PubMed  Google Scholar 

  34. Kouzi SA, Nuzum DS (2007) Arnica for bruising and swelling. Am J Health Syst Pharm 64:2434–2443

    Article  PubMed  Google Scholar 

  35. Alam M, Arndt KA, Dover JS (2002) Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases. J Am Acad Dermatol 46:62–65

    Article  PubMed  Google Scholar 

  36. Li M, Goldberger BA, Hopkins C (2005) Fatal case of BOTOX-related anaphylaxis? J Forensic Sci 50:169–172

    PubMed  Google Scholar 

  37. Crowner BE, Torres-Russotto D, Carter AR, Racette BA (2010) Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Clin Neuropharmacol 33:243–247

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Goldberg DJ (2009) Breakthroughs in US dermal fillers for facial soft-tissue augmentation. J Cosmet Laser Ther 11:240–247

    Article  PubMed  Google Scholar 

  39. Naoum C (2007) Dermal filler materials: a review. Kosmet Med 28:228–234

    Google Scholar 

  40. Jones DH (2009) Semipermanent and permanent injectable fillers. Dermatol Clin 27:433–444

    Article  CAS  PubMed  Google Scholar 

  41. Brandt FS, Cazzaniga A (2008) Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging 3:153–159

    CAS  PubMed Central  PubMed  Google Scholar 

  42. Wollina U, Goldman A (2011) Hyaluronic acid dermal fillers: safety and efficacy for the treatment of wrinkles, aging skin, body sculpturing and medical conditions. Clin Med Rev Therapeutics 3:107–121

    Article  Google Scholar 

  43. Lacombe V (2009) Sculptra: a stimulatory filler. Facial Plast Surg 25:95–99

    Article  CAS  PubMed  Google Scholar 

  44. Ridenour B, Kontis TC (2009) Injectable calcium hydroxylapatite microspheres (Radiesse). Facial Plast Surg 25:100–105

    Article  CAS  PubMed  Google Scholar 

  45. Carruthers J, Cohen SR, Joseph JH et al (2009) The science and art of dermal fillers for soft-tissue augmentation. J Drugs Dermatol 8:335–350

    PubMed  Google Scholar 

  46. Wollina U, Payne CR (2010) Aging well — the role of minimally invasive aesthetic dermatological procedures in women over 65. J Cosmet Dermatol 9:50–58

    Article  PubMed  Google Scholar 

  47. Lee I, Agarwal RK, Lee BY et al (2010) Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol 31:1219–1229

    Article  CAS  PubMed  Google Scholar 

  48. Alijotas-Reig J, Garcia-Gimenez V (2008) Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol 22:150–161

    CAS  PubMed  Google Scholar 

  49. Bachmann F, Erdmann R, Hartmann V et al (2009) The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg 35(Suppl 2):1629–1634

    Article  CAS  PubMed  Google Scholar 

  50. Naoum C (2010) Erythematous infiltrated nodules after implantation with hyaluronic acid — a severe case report. Kosmet Med 31:254–256

    Google Scholar 

  51. Rzany B, Becker-Wegerich P, Bachmann F et al (2009) Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use. J Cosmet Dermatol 8:317–323

    Article  PubMed  Google Scholar 

  52. Requena L, Requena C, Christensen L et al (2011) Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 64:1–34

    Article  CAS  PubMed  Google Scholar 

  53. Toy BR, Frank PJ (2003) Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg 29:971–973

    Article  PubMed  Google Scholar 

  54. Narins RS, Jewell M, Rubin M et al (2006) Clinical conference: management of rare events following dermal fillers-focal necrosis and angry red bumps. Dermatol Surg 32:426–434

    Article  CAS  PubMed  Google Scholar 

  55. Hariri LP, Gaissert HA, Brown R et al (2012) Progressive granulomatous pneumonitis in response to cosmetic subcutaneous silicone injections in a patient with HIV-1 infection: case report and review of the literature. Arch Pathol Lab Med 136:204–207

    Article  PubMed  Google Scholar 

  56. Wollina U (2012) Silicone injections. J Cutan Aesthet Med 5:197

    Google Scholar 

  57. Grunebaum LD, Bogdan Allemann I, Dayan S et al (2009) The risk of alar necrosis associated with dermal filler injection. Dermatol Surg 35 (Suppl 2):1635–1640

    Article  CAS  PubMed  Google Scholar 

  58. Kassir R, Kolluru A, Kassir M (2011) Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature. J Cosmet Dermatol 10:224–231

    Article  PubMed  Google Scholar 

  59. Alam M, Dover JS (2007) Management of complications and sequelae with temporary injectable fillers. Plast Reconstr Surg 120 (Suppl 6):98S–105S

    Article  CAS  PubMed  Google Scholar 

  60. Lazzeri D, Agostini T, Figus M et al (2012) Blindness following cosmetic injections of the face. Plast Reconstr Surg 129:995–1012

    Article  CAS  PubMed  Google Scholar 

  61. Park SW, Woo SJ, Park KH et al (2012) Iatrogenic retinal artery occlusion caused by cosmetic facial filler injections. Am J Ophthalmol 154:653–662

    Article  PubMed  Google Scholar 

  62. Cosatti M, Fernández Romero DS, Juri MC, Malbrán A (2010) Facial angioedema after filler injections. Description of five cases. Medicina (B Aires) 70:513–517

    Google Scholar 

  63. Wollina U (2009) Facial recontouring for late dermal filler complications. Kosmet Med 30:219–221

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Städtisches Klinikum, Akademisches Lehrkrankenhaus der TU, Dresden, Deutschland

    Uwe Wollina

  2. Clinica Goldman, Porto Alegre, Brasilien, Deutschland

    Alberto Goldman

  3. Department of Dermatology, Evangelismos Hospital, Athen, Griechenland

    Christos Naoum

  4. Klinik für Dermatologie und Allergologie, Krankenhaus Dresden-Friedrichstadt — Städtisches Klinikum, Akademisches Lehrkrankenhaus der TU Dresden, Friedrichstr. 41, 01067, Dresden, Deutschland

    Uwe Wollina

Authors
  1. Uwe Wollina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christos Naoum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uwe Wollina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wollina, U., Goldman, A. & Naoum, C. Spektrum, Management und Vermeidung. ästhet dermatol kosmetol 5, 16–23 (2013). https://doi.org/10.1007/s12634-013-0814-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12634-013-0814-4

Search

Navigation